Alteraciones del metabolismo hidrocarbonado en niños y adolescentes afectos de fibrosis quística

Olveira, 2008, Nutrición, Fibrosis Quística y Aparato Digestivo, Nutr Hosp., 23, 71 Barrio, 2009, Grupo de Trabajo de Fibrosis Quística. Protocolo de diagnóstico y seguimiento de los pacientes con fibrosis quística, An Pediatr., 71, 250, 10.1016/j.anpedi.2009.06.020 Barrio, 2004, Alteración del Metabolismo Hidrocarbonado en la Fibrosis Quística, An Pediatr., 60, 61 2021, Classification and Diagnosis of Diabetes, Diabetes Care., 44, S15 Hameed, 2015, Advances in the Detection and Management of Cystic Fibrosis-Related Diabetes, Curr Opin Pediatr., 27, 525, 10.1097/MOP.0000000000000251 Moran, 2018, ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents, Pediatr Diabetes., 19, 64, 10.1111/pedi.12732 Adler, 2011, Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes, Diabetes Care., 34, 1577, 10.2337/dc10-2289 Wood, 2004, Effect of hyperglycaemia on glucose concentration of human nasal secretions, Clin Sci., 106, 527, 10.1042/CS20030333 Moran, 2009, Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial, Diabetes Care., 32, 1783, 10.2337/dc09-0585 Moran, 2009, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality, Diabetes Care., 32, 1626, 10.2337/dc09-0586 Onady, 2016, Insulin and oral agents for managing cystic fibrosis-related diabetes, Cochrane Database Syst Rev., 4, CD004730 Moran, 2014, ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents, Pediatr Diabetes., 15, 65, 10.1111/pedi.12178 Hameed, 2010, Early glucose abnormalities in cystic fibrosis are preceded by por weight gain, Diabetes Care., 33, 221, 10.2337/dc09-1492 Brodsky, 2011, Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis, Diabetes Care., 34, 292, 10.2337/dc10-1604 Mainguy, 2017, Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?, J Pediatr Endocrinol Metab., 30, 27, 10.1515/jpem-2016-0184 O’Riordan, 2009, Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study, Diabetes Care., 32, 1020, 10.2337/dc08-1925 Schiafni, 2010, Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system, Eur J Endocrinol., 162, 705, 10.1530/EJE-09-1020 Ode, 2013, New insights into cystic fibrosis-related diabetes in children, Lancet Diabetes Endocrinol., 1, 52, 10.1016/S2213-8587(13)70015-9 Kayani, 2018, Cystic Fibrosis-Related Diabetes, Front. Endocrinol., 9, 20, 10.3389/fendo.2018.00020 Moheet, 2017, CF-related diabetes: containing the metabolic miscreant of cystic fibrosis, Pediatr Pulmonol., 52, S48, 10.1002/ppul.23762 Dobson, 2004, Conventional measures underestimate glycaemia in CF patients, Diabet Med., 21, 691, 10.1111/j.1464-5491.2004.01219.x Godbout, 2008, No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes, Diabetes Metab., 34, 568, 10.1016/j.diabet.2008.05.010 Martín-Frías, 2012, Alteraciones hidrocarbonadas en pacientes impúberes con fibrosis quística, An Pediatr., 77, 339, 10.1016/j.anpedi.2012.05.015 Ode, 2010, Oral Glucose Tolerance Testing in Children with Cystic Fibrosis, Pediatr Diabetes., 11, 487, 10.1111/j.1399-5448.2009.00632.x Hayashi, 2013, Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in japanese american, Diabetes Care., 36, 1229, 10.2337/dc12-0246 Quanjer, 2012, Age- and height-based prediction bias in spirometry reference equations, Eur Respir J., 40, 190, 10.1183/09031936.00161011 Piona, 2021, Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function, J Clin Endocrinol Metab., 106, e1793, 10.1210/clinem/dgaa932 Milla, 2000, Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline, Am J Respir Crit Care Med., 162, 891, 10.1164/ajrccm.162.3.9904075 Mozzillo, 2021, Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED), Front Endocrinol (Lausanne)., 12, 673539, 10.3389/fendo.2021.673539 Van den Berg, 2009, Demographics of Glucose Metabolism in Cystic Fibrosis, J Cyst Fibros., 8, 276, 10.1016/j.jcf.2009.04.010 Battezatti, 2011, Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients, Eur J Endocrinol., 165, 69, 10.1530/EJE-10-1003 Martos-Moreno, 2019, Sex, puberty, and ethnicity have a strong influence on growth and metabolic comorbidities in children and adolescents with obesity: Report on 1300 patients (the Madrid Cohort), Pediatr Obes., 14, e12565, 10.1111/ijpo.12565